156 related articles for article (PubMed ID: 17306604)
1. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis.
Kuroda Y; Nakao H; Ikemura K; Katoh T
Oral Oncol; 2007 Nov; 43(10):1043-8. PubMed ID: 17306604
[TBL] [Abstract][Full Text] [Related]
2. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
[TBL] [Abstract][Full Text] [Related]
3. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
Wang YC; Chen CY; Chen SK; Chang YY; Lin P
Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
[TBL] [Abstract][Full Text] [Related]
4. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
5. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
[TBL] [Abstract][Full Text] [Related]
6. TP53 codon 72 polymorphism in oral squamous cell carcinoma.
Drummond SN; De Marco L; Pordeus Ide A; Barbosa AA; Gomez RS
Anticancer Res; 2002; 22(6A):3379-81. PubMed ID: 12530090
[TBL] [Abstract][Full Text] [Related]
7. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
[TBL] [Abstract][Full Text] [Related]
9. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
11. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
[TBL] [Abstract][Full Text] [Related]
12. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
[TBL] [Abstract][Full Text] [Related]
13. p53 Codon 72 polymorphism in oral exfoliated cells in a Sudanese population.
Sand L; Jalouli MM; Jalouli J; Sapkota D; Ibrahim SO
In Vivo; 2012; 26(1):59-62. PubMed ID: 22210716
[TBL] [Abstract][Full Text] [Related]
14. Determination of p53 genotypes in oral cancer patients from India.
Tandle AT; Sanghvi V; Saranath D
Br J Cancer; 2001 Mar; 84(6):739-42. PubMed ID: 11259085
[TBL] [Abstract][Full Text] [Related]
15. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
16. TP53 codon 72 polymorphism is associated with pancreatic cancer risk in males, smokers and drinkers.
Sonoyama T; Sakai A; Mita Y; Yasuda Y; Kawamoto H; Yagi T; Yoshioka M; Mimura T; Nakachi K; Ouchida M; Yamamoto K; Shimizu K
Mol Med Rep; 2011; 4(3):489-95. PubMed ID: 21468597
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
[TBL] [Abstract][Full Text] [Related]
18. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx.
Sturgis EM; Dahlstrom KR; Guan Y; Eicher SA; Strom SS; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):273-5. PubMed ID: 11303599
[TBL] [Abstract][Full Text] [Related]
19. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
20. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
Boltze C; Roessner A; Landt O; Szibor R; Peters B; Schneider-Stock R
Int J Oncol; 2002 Nov; 21(5):1151-4. PubMed ID: 12370767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
